Market Help Live

RTE.ie

Biogen, Elan's Tysabri Will Lose Sales on Infections (Update1) Bloomberg - 1 hour ago By David Olmos Aug. 1 (Bloomberg) — Biogen Idec Inc. and Elan Corp.'s report about new potentially deadly infections linked to Tysabri will cause some physicians and patients to avoid the multiple- sclerosis therapy and raises concerns about whether … Safety Scares Hit Elan, Biogen And Schering Forbes S&P Picks and Pans: Elan, Biogen, Wachovia, GM, Nissan, Chevron … BusinessWeek MarketWatch - BioWorld Online - International Herald Tribune - TheStreet.com all 194 news articles

Original Post By Google News Click Here For The Entire Article

This entry was posted on Friday, August 1st, 2008 at 9:22 pm and is filed under Stock Investment Guide. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.